Background & aims:
Branched-chain amino acids (BCAAs) are considered markers of insulin resistance (IR) in subjects with obesity. In this study, we evaluated whether the presence of a single nucleotide polymorphism (SNP) of the branched-chain aminotransferase 2 (BCAT2) gene can modify the effect of a dietary intervention (DI) on the plasma concentration of BCAAs in subjects with obesity and IR.
Methods:
A prospective cohort study of adult subjects with obesity, body mass index (BMI) ≥ 30 kg/m2, IR (HOMA-IR ≥ 2.5) no diagnosed chronic disease, underwent a DI with an energy restriction of 750 kcal/d and nutritional education for one month. Anthropometric measurements, body composition, blood pressure, resting energy expenditure (REE), oral glucose tolerance test (OGTT) results, serum biochemical parameters and the plasma amino acid profile were evaluated before and after the DI. SNPs were assessed by the TaqMan SNP genotyping assay.
Results:
A total of 82 subjects were included, 15 subjects with a BCAT2 SNP had a greater reduction in leucine, isoleucine, valine, and the sum of BCAAs. Those subjects also had a greater reduction in skeletal muscle mass, fat free mass, total body water, blood pressure, muscle strength and biochemical parameters after one month of the DI and adjusting for age and sex.
Conclusions:
This study demonstrated that the presence of the BCAT2 SNP promotes a greater reduction in plasma BCAA concentration after adjusting for age and sex, in subjects with obesity and IR after a one-month energy-restricted DI.